Josh Lang
@joshlangmd.bsky.social
340 followers
180 following
53 posts
Professor and Associate Director of Translational Research, GU Medical Oncologist at the University of Wisconsin Carbone Cancer Center.
https://langlab.labs.wisc.edu/
#prostatecancer #cancerbiology #biomarkers
Posts
Media
Videos
Starter Packs
Reposted by Josh Lang
Reposted by Josh Lang
Reposted by Josh Lang
Don Moynihan
@donmoyn.bsky.social
· Jul 30
Reposted by Josh Lang
Josh Lang
@joshlangmd.bsky.social
· Jun 5
Reposted by Josh Lang
Reposted by Josh Lang
Reposted by Josh Lang
Reposted by Josh Lang
Reposted by Josh Lang
Mark Cuban
@mcuban.bsky.social
· Apr 17
Ohio Medicaid got rid of big middlemen. Says it paid pharmacies a lot more — and saved $140M • Ohio Capital Journal
The Ohio Department of Medicaid department in 2022 gave powerful prescription drug middlemen the boot and created a new system. The result: Fees paid to pharmacies were boosted more than 1,200% while ...
ohiocapitaljournal.com
Reposted by Josh Lang
Reposted by Josh Lang
Josh Lang
@joshlangmd.bsky.social
· Apr 10
Reposted by Josh Lang
Reposted by Josh Lang
Reposted by Josh Lang
Reposted by Josh Lang
Jeffrey Wuhl
@jeffreywuhl.bsky.social
· Mar 31
Reposted by Josh Lang
Reposted by Josh Lang
Reposted by Josh Lang
Davide Ruggero
@ruggerolab.bsky.social
· Mar 24
Small-molecule RNA therapeutics to target prostate cancer
Kuzuoglu-Ozturk et al. showcase a therapeutic approach, “translatome therapy,” to combat lethal prostate cancer. Zotatifin, a clinical molecule, targets the RNA-helicase eIF4A. Zotatifin decreases the select translation of key oncogenes, androgen receptor (AR), and HIF1α through remodeling their 5′ UTR RNA structure. Zotatifin enhances anti-androgen and radiotherapy sensitivity, highlighting a promising anti-cancer treatment.
www.cell.com
Reposted by Josh Lang
Jon Rauch
@jonrauch.bsky.social
· Mar 20